Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Gene screen to identify causes of autism

next article
16.10.2008

A new screening method can be used to detect the chromosomal abnormalities most commonly associated with autism spectrum disorders.

 

By screening for genetic defects associated with various kinds of cognitive impairment, the approach described in the open access journal BMC Medical Genomics will help clinicians identify the underlying causes of some patients’ autism spectrum disorders (ASDs).


Joseph Buxbaum from Mount Sinai School of Medicine, New York, led a team of researchers tasked with evaluating the use of ‘multiplex ligation-dependent probe amplification’ (MLPA), a recently developed method of investigating DNA, in genetic counselling. He said, “MLPA is a relatively practical, inexpensive and fast tool for screening chromosome rearrangements in autism spectrum disorders”.

ASDs have been increasingly associated with genetic abnormalities. At the same time, many children with ASDs also have some degree of cognitive impairment. In this study, the authors used MLPA on a group of 279 children with ASD, looking for abnormalities that are known to be associated with cognitive impairment. As Buxbaum describes, “By focussing on well-known genetic disorders, rather than assaying an individual’s entire genome, MLPA allows for much more efficiency”. As additional genetic abnormalities associated with ASDs are identified, additional probes can be used in future screens.

As well as demonstrating the effectiveness of MLPA as a screen for known genetic disorders, the authors also identified some new genetic changes that are likely to contribute to ASD, such as novel duplications (extra copies of genetic material) in chromosomes 15 and 22, which may increase liability and/or exacerbate ASD symptoms.

Although there is no known cure for ASDs, early detection and commencement of special education and behavioural therapy can mitigate some of the negative symptoms.

Graeme Baldwin | Source: alphagalileo
Further information:
www.biomedcentral.com/bmcmedgenomics/

next article

More articles from Life Sciences:

nachricht Scientists watch as peptides control crystal growth with ‘switches, throttles and brakes’
25.11.2009 | DOE/Lawrence Livermore National Laboratory

nachricht Arsenic and Gold Clusters
25.11.2009 | Angewandte Chemie International Edition

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News